Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brexpiprazole for irritability and sleep in hospitalized Alzheimer's disease patients
jRCT1061240123Recruiting
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of brexpiprazole in Alzheimer's disease (AD). Primary endpoint: Primary: Change in PSG-based sleep structure at 4 weeks. Started Feb 2025; status: recruiting.
02
Drugs
brexpiprazole
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on jRCT1061240123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1061240123.